Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell wall and cytoplasmic membrane components constitute the essential outer layers of a bacterial cell, collectively known as the cell envelope (Silhavy et al., 2010, Cold Spring Harb Perspect Biol). The cell wall is a rigid structure primarily composed of peptidoglycan that provides mechanical strength and protects the cell from osmotic lysis, while the cytoplasmic membrane is a phospholipid bilayer that regulates the transport of molecules and serves as the site for critical processes like oxidative phosphorylation (Sarkar et al., 2017, Molecules). These components are fundamental targets for antimicrobial therapy because many of their structural elements, such as the peptidoglycan layer, are unique to bacteria and absent in human cells, ensuring selective toxicity (Silver, 2011, Clin Microbiol Rev). Drugs like beta-lactams and glycopeptides interfere with the assembly of the cell wall by inhibiting transpeptidases or binding to peptidoglycan precursors, leading to structural failure and cell death (StatPearls, 2023, Penicillin). Conversely, agents like daptomycin and polymyxins target the cytoplasmic membrane, causing depolarization or physical disruption that results in the leakage of essential ions and metabolites (Zasloff, 2002, Nature). The clinical utility of targeting these structures is often complicated by the development of resistance, such as the production of beta-lactamases or the modification of membrane lipids to reduce drug binding (Munita & Arias, 2016, Microbiol Spectr).
Inhibition of peptidoglycan synthesis and cross-linking; disruption of membrane integrity and membrane potential.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell wall and cytoplasmic membrane components.